 | | Vol. 10.02 – 21 January, 2021 |
| |
|
|
| Researchers observed that transduced ribosomal protein S19 (Rps19)-deficient bone marrow cells could reconstitute mice longterm and rescue the bone marrow failure and severe anemia observed in Rps19-deficient mice, with a low risk of mutagenesis and a highly polyclonal insertion site pattern.
[Haematologica] |
|
 |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors assessed the potential anti-inflammatory effects of human umbilical cord MSC-derived extracellular vesicles in a rat model of chronic obstructive pulmonary disease.
[Stem Cell Research & Therapy] |
|
|
|
| Scientists characterized the protein secretome of adipose, bone marrow, placenta, and Wharton’s jelly-derived human MSCs by using conditioned media and analyzing the secretome by mass spectrometry and follow-up bioinformatics.
[International Journal of Molecular Sciences] |
|
|
|
| Researchers demonstrated the recovery of viable total nucleated cells and CD34+ cells, as well as the mononuclear cell viability in 20-year-old cryopreserved cord blood (CB) units in a CB bank.
[Journal of Clinical Medicine] |
|
|
|
| When human umbilical cord MSCs were transplanted directly, only a minority of cells migrated toward damaged tissues. Their maintenance time was short, leading to unsatisfactory therapeutic results.
[Stem Cells and Development] |
|
|
|
| Images from previous work, where human Wharton’s Jelly cells were differentiated into mechanosensory hair cell-like cells, were examined. Various cell features were extracted from these images, and those which were pertinent to classification were identified.
[PLoS One] |
|
|
|
|
| Investigators outline the results of preclinical research on fetal stem cell therapy, mainly involving human amniotic fluid stem cells, in the context of perinatal neurological diseases.
[Placenta] |
|
|
|
|
| Bone Therapeutics and Rigenerand SRL, the biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and oncology, announced the signing of a first agreement for a process development partnership.
[Bone Therapeutics] |
|
|
|
|
|
|
| | St. Jude Children’s Hospital – Memphis, Tennessee, United States |
|
|
|
| | STEMCELL Technologies, Inc. – Burnaby, British Columbia, Canada |
|
|
|
| | University of Colorado – Aurora, Colorado, United States |
|
|
|
| | Fondazione Human Technopole – Milan, Italy |
|
|
|
| | Columbia University Medical Center – New York, New York, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
